Elmiron Lawyers | Columbus Ohio | Clark, Perdue & List Co, LPA

During these unprecedented times, Clark, Perdue, & List Co, LPA is here to fully support your needs in a timely and safe manner. COVID-19 should not affect your ability to investigate a personal injury case. We currently remain open and are still accepting new cases. With your safety top of mind, we are scheduling all meetings via telephone or video conference at this time.

Elmiron Lawyers in Columbus, OH

What is Elmiron?

Elmiron is a medication used to treat a chronic condition called interstitial cystitis, bladder and pelvic pain. Recently, scientific research has discovered a link between Elmiron and pigmentary maculopathy—one of the leading causes of blindness in American adults.  Symptoms of maculopathy, or macular degeneration, can include gradual loss of vision, blurry vision, sensitivity to light and loss of low-light visibility.   Unfortunately, these symptoms can be irreversible.

Elmiron and Its Risks

Elmiron is a popular medication used to treat interstitial cystitis and painful bladder syndrome. According to the Urology Care Foundation,  they estimate that 1 to 4 million men and 3 to 8 million women have symptoms of IC/BPS. At the moment, Elmiron is the only FDA approved medication to treat this condition. Because of this fact, thousands of people have been exposed to this medication and its side effects over many years. Doctors recommend patients consult with their urologist regarding their use of this medication along with yearly screenings for patients who are not currently exhibiting signs of pigmentary maculopathy.

The drug has recently been associated with a significantly increased risk of pigmentary maculopathy, which results from chronic and permanent damage to the retina. Injuries can range from irreparable vision impairment to blindness, which can progress even after patients stop taking the drug.

Specific diagnoses and side effects of Elmiron include:

• Blindness (bilateral)

• Blurred vision

• Macular degeneration

• Pattern Dystrophy

• Pigmentary maculpathy

• Vision disturbances

• Vision impairment

• Vision loss

Do you believe your eye problems are linked to Elmiron?

Are You Eligible for a Claim?

If you or a loved one has developed blindness after taking Elmiron, you may be eligible for compensation. Contact our attorneys for a free consultation to discuss your potential case. 

Like millions of Americans, you may have taken this drug that was deemed to be safe and effective. Now you may be unfortunately stricken with a life-threatening disease that will physically, emotionally, and financially burden you and your loved ones. Let us help you and your family get justice. Call us today! You will receive:

  1. Free consultation over the phone
  2. Easy consultation, with no obligations
  3. Case review from an experienced drug injury lawyer

If you or a loved one has been harmed by a dangerous drug, such as Elmiron, contact us for a free consultation today. You may be entitled to financial compensation.

RECENT BLOG POSTS ABOUT DANGEROUS DRUGS

Elmiron & Blindness

Clark Perdue is proud of its decades long of counsel relationship with Anapol Weiss.  The collaborative effort between our firms has proven effective time and again in the representation of our mutual clients. We are pleased to announce that Anapol Weiss' Senior...

read more

FDA Proposes Recall of Zantac

The Food and Drug Administration has requested drug manufacturers recall the popular heart burn medication, Zantac. This move comes as a continuing FDA investigation has found that Zantac, and other drugs with the active ingredient ranitidine, often contain...

read more

Zantac Linked to Cancer Risk When Stored in High Heat

In a previous post, we wrote about the FDA's investigation into the heartburn medication, Zantac, and other drugs containing ranitidine. The problem is that ranitidine has been found to contain N-Nitrosodimethylamine (“NDMA”), a suspected cancer causing agent in...

read more

Zantac Cancer Risk

Zantac, a popular heartburn medication, has been pulled from major retailers shelves because some of its ingredients may be linked to Zantac cancer risk.  The Food and Drug Administration ("FDA") continues to investigate the Zantac cancer risk, noting that "FDA is...

read more

Taxotere Hair Loss MDL Ordered

The Judicial Panel on Multidistrict Litigation ordered consolidation of all Taxotere hair loss cases on October 2, 2016. The panel noted that nearly 90 cases, alleging permanent hair loss resulting for the use of the chemotherapy drug, Taxotere, have been filed...

read more

Study Links Proton Pump Inhibitors to Stroke

Clark, Perdue & List is actively investigating cases involving patients suffering from kidney damage as a result of using popular heart burn medications, including Nexium, Prilosec, and Prevacid, have been linked to kidney damage. Studies have shown a link between...

read more